Florian Rüker

8PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2025
Trispecific SEED antibodies engineered for neutrophil-mediated cell killing.

Veronica Natale, Gergely Heves, Katharina Stadlbauer

|Dec 27, 2024
Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies.

Gregor Rossmueller, Irina Mirkina, Michael Thiele

|Oct 14, 2023
Development of a Cytotoxic Antibody-Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells.

Aleksandra Rodak, Katharina Stadlbauer, Madhusudhan Reddy Bobbili

|May 14, 2022
Bispecific mAb2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab.

Katharina Stadlbauer, Peter Andorfer, Gerhard Stadlmayr

|Nov 27, 2021
A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation.

Filippo Benedetti, Katharina Stadlbauer, Gerhard Stadlmayr

|Nov 27, 2021
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE.

Aleksandra Rodak, Gerhard Stadlmayr, Katharina Stadlbauer

Pageof 2